Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3194423 | 0.84 | NR4A1 (0.46) | KMT2AKDM4EALDH1A1MAPK14MAPT | |
| SCHEMBL9332586 | 0.79 | RAB9A (0.47) | ATMKMT2AKDM4EALDH1A1GAA | |
| SCHEMBL9332576 | 0.79 | KMT2A (0.44) | ATMKMT2AKDM4EALDH1A1GAA | |
| SCHEMBL28639283 | 0.71 | ATM (0.75) | ATMKMT2AKDM4EALDH1A1GAA | |
| SCHEMBL1193736 | 0.71 | IDO1 (0.44) | ATMKMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL450730 | 0.71 | CHKA (0.46) | KMT2AKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL17145456 | 0.70 | KDM4E (0.40) | KMT2AKDM4EALDH1A1GAAMAPT | |
| SCHEMBL6827498 | 0.69 | MAPT (0.38) | ATMKDM4EMAPK14MAPTMITF | |
| SCHEMBL633559 | 0.68 | RAB9A (0.36) | KDM4EGAAMAPTTSHRMITF | |
| SCHEMBL3367760 | 0.68 | RAB9A (0.61) | KMT2AKDM4EALDH1A1MAPK14MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729067-A2 | ELECTRODE ASSEMBLY FOR APPLYING TUMOR TREATING FIELDS WITH A SHEET OF ANISOTROPIC MATERIAL | Novocure GmbH (CH) | 2026-04-22 | — | — | EP | disclosed |
| EP-4344414-A1 | ELECTRODE ASSEMBLY FOR APPLYING TUMOR TREATING FIELDS (TTFIELDS) WITH A SHEET OF ANISOTROPIC MATERIAL | Novocure GmbH (CH) | 2024-04-03 | — | — | EP | disclosed |
| CN-117715678-A | Electrode assembly for applying a Tumor Treatment Field (TTFIELD) using an anisotropic sheet of material | 诺沃库勒有限责任公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-109641864-B | Anti-infective agents | 邓迪大学 | 2023-04-04 | — | — | CN | disclosed |
| US-20230037806-A1 | Electrode Assembly for Applying Tumor Treating Fields (TTFields) with a Sheet of Anisotropic Material | NOVOCURE GMBH (CH) | 2023-02-09 | — | — | US | disclosed |
| WO-2023012707-A1 | ELECTRODE ASSEMBLY FOR APPLYING TUMOR TREATING FIELDS (TTFIELDS) WITH A SHEET OF ANISOTROPIC MATERIAL | NOVOCURE GMBH (CH) | 2023-02-09 | — | — | WO | disclosed |
| US-11485720-B2 | Anti-infective agents | UNIVERSITY OF DUNDEE (GB) | 2022-11-01 | — | — | US | disclosed |
| EP-3472141-B1 | ANTI-INFECTIVE AGENTS | UNIV DUNDEE (GB) | 2022-10-05 | — | — | EP | disclosed |
| US-20210101877-A1 | ANTI-INFECTIVE AGENTS | UNIVERSITY OF DUNDEE (GB) | 2021-04-08 | — | — | US | disclosed |
| US-20190225592-A1 | ANTI-INFECTIVE AGENTS | UNIVERSITY OF DUNDEE (GB) | 2019-07-25 | — | — | US | disclosed |
| EP-3472141-A1 | ANTI-INFECTIVE AGENTS | University Of Dundee (GB) | 2019-04-24 | — | — | EP | disclosed |
| WO-2017221002-A1 | ANTI-INFECTIVE AGENTS | UNIVERSITY OF DUNDEE (GB) | 2017-12-28 | — | — | WO | disclosed |
| EP-2836483-B1 | ANTI-MALARIAL AGENTS | MERCK PATENT GMBH (DE) | 2016-07-27 | — | — | EP | disclosed |
| US-9115088-B2 | Anti-malarial agents | MERCK PATENT GMBH (DE) | 2015-08-25 | — | — | US | disclosed |
| EP-2836483-A1 | ANTI-MALARIAL AGENTS | University Of Dundee (GB) | 2015-02-18 | — | — | EP | disclosed |
| EP-2836483-A1 | ANTI-MALARIAL AGENTS | University Of Dundee (GB) | 2015-02-18 | — | — | EP | disclosed |
| US-20150045354-A1 | Anti-Malarial Agents | MERCK PATENT GMBH (DE) | 2015-02-12 | — | — | US | disclosed |
| WO-2013153357-A1 | ANTI-MALARIAL AGENTS | UNIVERSITY OF DUNDEE (GB) | 2013-10-17 | — | — | WO | disclosed |
| WO-2013153357-A1 | ANTI-MALARIAL AGENTS | UNIVERSITY OF DUNDEE (GB) | 2013-10-17 | — | — | WO | disclosed |
| CN-1681803-A | Aroyl-piperidine derivatives | NOVARTIS AG (CH) | 2005-10-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11485720-B2 | Anti-infective agents | C1R, RRS1, ARG1 | ATM 3574/4885KMT2A 3024/4885KDM4E 2159/4885 |
| US-20150045354-A1 | Anti-Malarial Agents | PRMT7, MRPS7, RAB7A | ATM 4234/4885KMT2A 2494/4885KDM4E 1213/4885 |
| US-20210101877-A1 | ANTI-INFECTIVE AGENTS | C1R, RRS1, ARG1 | ATM 3574/4885KMT2A 3024/4885KDM4E 2159/4885 |
| US-20190225592-A1 | ANTI-INFECTIVE AGENTS | C1R, ARG1, MSR1 | ATM 3612/4885KMT2A 3120/4885KDM4E 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.